HENRY SCHEIN INCHSIC

時価総額
$95.9億
PER
23倍
2010年
12月25日
2011年
12月31日
2012年
12月29日
2013年
12月28日
2014年
12月27日
2015年
12月26日
2016年
12月31日
2017年
12月30日
2018年
12月29日
2019年
12月28日
2020年
12月26日
2021年
12月25日
2022年
12月31日
2023年
12月30日
Net Income352405423471505523556459562719419661566436
Income from discontinued operations----------61---
Depreciation and amortization101116125128152159170193208185186210212248
Impairment charge on intangible assets----------201347
Non-cash restructuring charges------------9327
Capitalized Computer Software Impairments 1-------------27
Gain on sale of equity investment---------250210--
Non-cash restructuring charges------------9327
Share-based Compensation303737364645584236459785439
Gain on sale of equity investment---------250210--
Provision for Doubtful Accounts66455339151335-8518
Share-based Compensation303737364645584236459785439
Benefit from deferred income taxes----------4-53-11-73-20
Provision for Doubtful Accounts66455339151335-8518
Equity in earnings of affiliates101671012141917221812201514
Benefit from deferred income taxes----------4-53-11-73-20
Distributions from equity affiliates-15141716182023217116181515
Equity in earnings of affiliates101671012141917221812201514
Changes in unrecognized tax benefits--------2-12-25-21210
Distributions from equity affiliates-15141716182023217116181515
Benefit from transition tax---------10-----
Changes in unrecognized tax benefits--------2-12-25-21210
Other-61421-3-8-12-111-6-510203
Accounts receivable-7636-74-4581120216014773189-47327
Inventories-21-44-194-487219510517585-1532295126-231
Other current assets----4058238692576-952138
Accounts payable and accrued expenses27171166743213-268924216122485-96-56
Income from continuing operations352405-------725418661566-
Net cash provided by operating activities389555408----546685654599710602500
Depreciation and amortization101116125128152159170193208185186210212248
Impairment charge on intangible assets----------201347
Non-cash restructuring charges------------9327
Capitalized Computer Software Impairments 1-------------27
Gain on sale of equity investment---------250210--
Non-cash restructuring charges------------9327
Share-based Compensation303737364645584236459785439
Gain on sale of equity investment---------250210--
Provision for Doubtful Accounts66455339151335-8518
Share-based Compensation303737364645584236459785439
Benefit from deferred income taxes----------4-53-11-73-20
Provision for Doubtful Accounts66455339151335-8518
Equity in earnings of affiliates101671012141917221812201514
Benefit from deferred income taxes----------4-53-11-73-20
Distributions from equity affiliates-15141716182023217116181515
Equity in earnings of affiliates101671012141917221812201514
Changes in unrecognized tax benefits--------2-12-25-21210
Distributions from equity affiliates-15141716182023217116181515
Benefit from transition tax---------10-----
Changes in unrecognized tax benefits--------2-12-25-21210
Other-61421-3-8-12-111-6-510203
Accounts receivable-7636-74-4581120216014773189-47327
Inventories-21-44-194-487219510517585-1532295126-231
Other current assets----4058238692576-952138
Accounts payable and accrued expenses27171166743213-268924216122485-96-56
Net cash provided by operating activities from continuing operations---664593587615--820594710602-
Net cash provided by operating activities from discontinued operations----------1665---
Net cash provided by operating activities389555408----546685654599710602500
Purchases of fixed assets39455160827270829176497996147
Payments related to equity investments and business acquisitions, net of cash acquired4001492201824241722292896265660571158955
Proceeds from sale of equity investment-------3413071410--
Proceeds from loan to affiliate---------2617-1-4116
Other-447111317186161419333321
Payments For Proceeds From Hedge Investing Activities--------------22
Net cash used in investing activities from continuing operations----267-517-260-316---422-115-677--
Capitalized Software Costs, Investment Activities-------------40
Net cash used in investing activities from discontinued operations----------2----
Other-447111317186161419333321
Net cash used in investing activities-428-196-270-----342-193-424-115-677-276-1,135
Net change in bank borrowings----15314599303211-92845-1848153
Proceeds from issuance of long-term debt110315567931513526120011515013052701,368
Principal payments for long-term debt266344173022820115602826161112259468
Debt issuance costs--1110021043-3
Debt extinguishment costs----------0---
Proceeds from Stock Options Exercised38357236311511530--21
Payments for repurchases of common stock5820030030030030055045020052574401485250
Payments for taxes related to shares withheld for employee taxes-------4518111473234
Proceeds from Sale of Interest in Corporate Unit---------1,120----
Proceeds from Contributions from Affiliates---------361----
Distributions to noncontrolling stockholders---------51-8-25-21-47
Acquisitions of noncontrolling interests in subsidiaries------------3819
Proceeds from Henry Schein Animal Health Business-----------3---
Net cash used in financing activities from continuing operations----336-155-319-300---363-182-333-315-
Net cash used in financing activities-283-354-171-----113-604-216-187-333-315701
Net cash provided by (used in) financing activities from discontinued operations---------147-5---
Net cash used in financing activities-283-354-171-----113-604-216-187-333-315701
Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations---------1418-3-12-
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations--------------12
Effect of Exchange Rate on Cash and Cash Equivalents, Discontinued Operations----------2----
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect---------52315--54
Net change in cash and cash equivalents from continuing operations------------303-1-
Net change in cash and cash equivalents from discontinued operations----------23----